GGrantIndex
← Search

A PHASE II/III RANDOMIZED, OPEN-LABEL STUDY OF COMBINATION ANTIRETROVIRAL REG

$2,215M01FY2007RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →